Rocket Pharmaceuticals Inc
Research Rocket Pharmaceuticals Inc (RCKT) on Bullrun: market cap USD 367.98M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerRCKT
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 367.98M
- Financial periodFY2025
- Net income-USD 223.12M
- Free cash flow-USD 190.45M
Valuation Snapshot
latest market cap is USD 367.98M.
About Rocket Pharmaceuticals Inc
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing, manufacturing, and selling of genetic therapies for rare and devastating diseases in the United States. It develops in vivo adeno-associated viral (AAV) programs, which include programs for Danon disease (DD), a multi-organ lysosomal-associated disorder leading to early death due to heart failure (RP-A501), which is in Phase 2 trial;
Frequently asked questions
What is Rocket Pharmaceuticals Inc's market cap?
Rocket Pharmaceuticals Inc's market capitalization is USD 367.98M.
What does Rocket Pharmaceuticals Inc do?
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing, manufacturing, and selling of genetic therapies for rare and devastating diseases in the United States.